Akihito Yokoyama
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Akihito Yokoyama has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Nobuoki Kohno
A Department of Molecular and Internal Medicine , Graduate School of Biomedical and Health Sciences, Hiroshima University , Hiroshima , Japan
8 shared publications Kunio Hiwada
6 shared publications- Noboru Hattori
Department of Respiratory Medicine, Hiroshima University Hospital, Hiroshima 734-8551, Japan
6 shared publications - Takayuki Ikezoe
Department of Hematology Fukushima Medical University Fukushima Japan
5 shared publications - Hiroshi Ohnishi
Department of Respiratory Medicine and Allergology, Kochi Medical School, Kochi University, Kochi, Japan
4 shared publications Chie Nishioka
Department of Hematology and Respiratory Medicine, Kochi Medical School, Kochi University, Nankoku, Kochi, Japan
3 shared publications
Latest Publications
- Open Access
- 12 November 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (5) , 1103-1110.e9
Brain-Derived Neurotrophic Factor Levels Are Associated With Depressive Symptoms in Patients With Asthma
- 12 November 2025
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 14 (5) , 1103-1110.e9
Open AccessBrain-Derived Neurotrophic Factor Levels Are Associated With Depressive Symptoms in Patients With Asthma
- Open Access
- 7 March 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (3) , 276
Influence of Educational Films on Antiviral Prescription for COVID-19: Insights from Web-Based Survey in Japan
Background: Prescribing antiviral agents for severe acute respiratory syndrome coronavirus 2 requires careful consideration based on the patient’s risk factors for severe disease progression and their vaccination status. However, effective interventions ensuring the appropriate use of antiviral agents by physicians have yet to be fully established. Thus, this study evaluated the impact of an educational film on antiviral prescription rates for coronavirus disease 2019 (COVID-19). Methods: This prospective, nationwide, web-based survey enrolled 1500 physicians. They were instructed to view a short educational film and assess the necessity of prescribing antiviral agents in 16 fictitious scenarios featuring adult patients with COVID-19 with varying risk factors for severe disease and vaccination statuses. We compared the antiviral prescription rates before and after viewing the educational film. Results: There was a significant increase in the antiviral prescription rates after viewing the educational film, particularly nirmatrelvir/ritonavir prescribed in cases involving immunocompromised patients (from 31.3% to 49.4%) and those with obesity (from 15.1% to 33.7%) who were unvaccinated and had no risk of drug interactions. However, viewing the educational film made little to no impact on the prescription rates for the patients with hypertension and hyperlipidemia or those with no underlying conditions. Conclusions: Short educational films may promote the appropriate use of antiviral agents for COVID-19. However, their impact on altering prescription behavior appears limited and varies according to the clinical context.
- 7 March 2025
- Published by MDPI AG in Antibiotics
- Vol. 14 (3) , 276
Open AccessInfluence of Educational Films on Antiviral Prescription for COVID-19: Insights from Web-Based Survey in Japan
Background: Prescribing antiviral agents for severe acute respiratory syndrome coronavirus 2 requires careful consideration based on the patient’s risk factors for severe disease progression and their vaccination status. However, effective interventions ensuring the appropriate use of antiviral agents by physicians have yet to be fully established. Thus, this study evaluated the impact of an educational film on antiviral prescription rates for coronavirus disease 2019 (COVID-19). Methods: This prospective, nationwide, web-based survey enrolled 1500 physicians. They were instructed to view a short educational film and assess the necessity of prescribing antiviral agents in 16 fictitious scenarios featuring adult patients with COVID-19 with varying risk factors for severe disease and vaccination statuses. We compared the antiviral prescription rates before and after viewing the educational film. Results: There was a significant increase in the antiviral prescription rates after viewing the educational film, particularly nirmatrelvir/ritonavir prescribed in cases involving immunocompromised patients (from 31.3% to 49.4%) and those with obesity (from 15.1% to 33.7%) who were unvaccinated and had no risk of drug interactions. However, viewing the educational film made little to no impact on the prescription rates for the patients with hypertension and hyperlipidemia or those with no underlying conditions. Conclusions: Short educational films may promote the appropriate use of antiviral agents for COVID-19. However, their impact on altering prescription behavior appears limited and varies according to the clinical context.
- Open Access
- 15 October 2023
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 62 (20) , 3093-3094
Tracheobronchial Tuberculosis Mimicking Malignancy on Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- 15 October 2023
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 62 (20) , 3093-3094
Open AccessTracheobronchial Tuberculosis Mimicking Malignancy on Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography
Access full-text academic articles: J-STAGE is an online platform for Japanese academic journals.
- Open Access
- 26 April 2023
- Published by Elsevier in Allergology International
- Vol. 72 (4) , 537-544
Real-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study
- 26 April 2023
- Published by Elsevier in Allergology International
- Vol. 72 (4) , 537-544
Open AccessReal-world impact of dupilumab on asthma disease burden in Japan: The CROSSROAD study
- 27 February 2023
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 196, 110753
Evaluation of a therapeutic carbon beam using a G2000 glass scintillator
- 27 February 2023
- Published by Elsevier in Applied Radiation and Isotopes
- Vol. 196, 110753
Evaluation of a therapeutic carbon beam using a G2000 glass scintillator
- 23 May 2022
- Published by Elsevier in Respiratory Investigation
- Vol. 60 (5) , 640-646
Impact of coronavirus disease 2019 on respiratory care in Japan: A nationwide survey by the Japanese Respiratory Society
- 23 May 2022
- Published by Elsevier in Respiratory Investigation
- Vol. 60 (5) , 640-646
Impact of coronavirus disease 2019 on respiratory care in Japan: A nationwide survey by the Japanese Respiratory Society
- Open Access
- 1 January 2022
- Published by Elsevier in Allergology International
- Vol. 71 (1) , 47-54
Regional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data
- 1 January 2022
- Published by Elsevier in Allergology International
- Vol. 71 (1) , 47-54
Open AccessRegional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data
- 1 May 2021
- Published by Elsevier in Respiratory Investigation
- Vol. 59 (3) , 320-326
Association between airflow limitation and leukoaraiosis of the brain
- 1 May 2021
- Published by Elsevier in Respiratory Investigation
- Vol. 59 (3) , 320-326
Association between airflow limitation and leukoaraiosis of the brain
- 1 December 2017
- Published by Elsevier in Leukemia Research
- Vol. 63, 1-9
In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome
- 1 December 2017
- Published by Elsevier in Leukemia Research
- Vol. 63, 1-9
In vitro studies on the role of recombinant human soluble thrombomodulin in the context of retinoic acid mediated APL differentiation syndrome
- Open Access
- 18 August 2017
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 9 (1) , 63
Association between aerobic capacity and the improvement in glycemic control after the exercise training in type 2 diabetes
We investigated the influence of aerobic capacity on the improvement in glycemic control achieved by long-term aerobic exercise in type 2 diabetes. Fifty-three male patients with type 2 diabetes, recruited from outpatient clinics, wore multiple-memory accelerometers and were instructed to exercise at moderate intensity for ≥30 min on ≥3 days per week over 12 months. Peak oxygen uptake (peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 ) and serum glycated albumin (GA) were measured at baseline and after 3, 6, 12 months. Peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 data were expressed as percentages of predicted values. According to the number of bouts of exercise (intensity, ≥4 METs; duration, ≥15 min), the subjects were divided into inactive (<3 times per week) or active (≥3 times per week) groups. Serum GA decreased significantly after 3, 6, 12 months only in the active group. When the subjects were assigned to four groups according to initial peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 (%pred) (low-fitness or high-fitness) and the number of bouts of exercise (active or inactive), serum GA decreased significantly after 3, 6, 12 months only in the high-fitness/active group. When the subjects were also assigned to four groups according to the change in peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 (%pred) (improved or unimproved) and the number of bouts of exercise (active or inactive), serum GA decreased significantly after 3 and 12 months only in the improved/active group. The improvement in glycemic control achieved by aerobic exercise was associated with both the initial and the increase in peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 during aerobic exercise.- 18 August 2017
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 9 (1) , 63
Open AccessAssociation between aerobic capacity and the improvement in glycemic control after the exercise training in type 2 diabetes
We investigated the influence of aerobic capacity on the improvement in glycemic control achieved by long-term aerobic exercise in type 2 diabetes. Fifty-three male patients with type 2 diabetes, recruited from outpatient clinics, wore multiple-memory accelerometers and were instructed to exercise at moderate intensity for ≥30 min on ≥3 days per week over 12 months. Peak oxygen uptake (peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 ) and serum glycated albumin (GA) were measured at baseline and after 3, 6, 12 months. Peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 data were expressed as percentages of predicted values. According to the number of bouts of exercise (intensity, ≥4 METs; duration, ≥15 min), the subjects were divided into inactive (<3 times per week) or active (≥3 times per week) groups. Serum GA decreased significantly after 3, 6, 12 months only in the active group. When the subjects were assigned to four groups according to initial peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 (%pred) (low-fitness or high-fitness) and the number of bouts of exercise (active or inactive), serum GA decreased significantly after 3, 6, 12 months only in the high-fitness/active group. When the subjects were also assigned to four groups according to the change in peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 (%pred) (improved or unimproved) and the number of bouts of exercise (active or inactive), serum GA decreased significantly after 3 and 12 months only in the improved/active group. The improvement in glycemic control achieved by aerobic exercise was associated with both the initial and the increase in peak $${\dot{\text{V}}\text{O}}_{ 2}$$ V ˙ O 2 during aerobic exercise.